Expert opinion on "Results of a pilot clinical trial of the safety and efficacy of an original glycoprotein IIb/IIIa receptor inhibitor drug in acute coronary syndrome"

1. Isezuo S, Sani MU, Talle A, Johnson A, et al. RACE‐Nigeria Registry Investigators. Registry for Acute Coronary Events in Nigeria (RACE-Nigeria): Clinical Characterization, Management, and Outcome. J Am Heart Assoc. 2022;11(1):e020244. doi:10.1161/JAHA.120.020244.

2. Martsevich SYu, Ginzburg ML, Kutishenko NP, et al. A Lyubertsy study of mortality among patients with prior acute myocardial infarction: the first results of the LIS study. The Clinician. 2011;5(1);24-8. (In Russ.) EDN NDCYFH.

3. Masoudi F, Ponirakis A, Yeh R, et al. Cardiovascular Care Facts: A Report From the National Cardiovascular Data Registry: 2011. J Am Coll Cardiol. 2013;62(21):1931-1947. doi:10.1016/j.jacc.2013.05.099.

4. Yu T, Jiao Y, Song J, et al. Hospital mortality in acute coronary syndrome: adjustment of GRACE score by D-dimer enables a more accurate prediction in a prospective cohort study. BMC Cardiovasc Disord. 2019;19(1):252. doi:10.1186/s12872-0191239-4.